Adocia

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Takeda, F-star Sign Joint Research Pact

After seeing its shares soar by 250% in May after revealing late-stage negotiations with a “major global pharmaceutical company” for NBTXR3, Nanobiotix SA has unveiled Johnson & Johnson as the par

Cash is flooding into biopharmaceuticals, but regenerative medicine companies in particular have raked in large sums of cash – in part, because of the high upfront investment in manufacturing, but als

No longer just a Unilever PLC spin-out helping pharma reformulate drugs, Arecor Ltd. has now made the first moves to becoming a drug development company in its own right. With money in the bank fr